ID: MRFR/HC/7160-HCR | February 2021 | Region: Global | 90 pages
Aortic Valve Market held a value of USD 6,454.91 Million in 2018, at a CAGR of 11.1% during the assessment period of 2019 to 2025.
There has been significant growth in the adoption of minimally invasive surgeries in the past few years, which is why demand for aortic valves is also increasing. The key players involved in this market are actively focusing upon building partnerships, collaborations, and joint ventures with hospitals and ambulatory centers in different countries to strengthen their position in the market. Moreover, there is an increasing growth in cardiovascular diseases, which pushes the need for efficient aortic valves in the developing as well as underdeveloped regions.
Several government authorities and associations from developed and developing regions have focused on increasing awareness about valve replacement procedures is contributing to the growth of the market. For instance, the European Society of Cardiology organizes ESC Congress where heart experts from more than 150 countries come together to attend scientific sessions.
By Valve Type
By Surgery Type
|Market Size||USD 6,454.91 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors and Trends|
|Segments Covered||Valve Type, Surgery Type, End-User And Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Boston Scientific Corporation, Medtronic, Abbott Laboratories, LivaNova PLC, Edwards Lifesciences Corporation, CryoLife, Biotronik, Colibri Heart Valve, JenaValve, TTK HealthCare|
|Key Market Opportunities||Adoption of minimally invasive surgeries|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Aortic Valve Market is projected to grow at approximately 11.1% CAGR during the assessment period (2019-2025).
Aortic Valve Market had valued at around USD 6,454.91 MN in 2018.
Surging prevalence of cardiac disorders and introduction of innovative products, are major tailwinds pushing the growth of the Global Aortic Valve Market.
North America holds the largest share in the Global Aortic Valve Market, followed by Europe and the Asia Pacific, respectively.
Medtronic(US), TTK HealthCare (India), Boston Scientific Corporation (US), JenaValve (US), Abbott Laboratories (US), Biotronik (Germany), Edwards Lifesciences Corporation (2025US), Colibri Heart Valve (US), LivaNova PLC (UK), and CryoLife (US), are some of the top players operating in the Global Aortic Valve Market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.